Published on October 31st, 20190
TINA.org obtained the letters through a Freedom of Information Act request. One of the firms was Knightline Legal.
Here’s what one of the Knightline Legal TV ads cited in the letter said:
If you or a loved one used a proton pump inhibitor such as Nexium, Prilosec, or Prevacid and then developed stomach cancer, call right now … A recent medical study found that the prolonged use of both prescription and over-the-counter proton-pump inhibitors may double a patient’s risk of developing stomach cancer.
And what the FTC said:
We note that the study referenced in the ad found that PPI use was associated with an additional 4.29 gastric cancer cases per 10,000 people per year, amounting to a very small, .043-percent increase in risk. Accordingly, the implication that the study establishes that a prolonged use of PPIs poses a substantial risk of stomach cancer appears to be false.
Find more of our coverage on pharmaceuticals here.